Esperion Therapeutics Inc Logo Image

Esperion Therapeutics Inc

Esperion Therapeutics Inc Banner Image

Most Recent Annual Report

2019 Annual Report and Form 10K

Esperion Therapeutics Inc

Esperion Therapeutics Inc has reached its limit for free report views.

Esperion Therapeutics Inc does not currently have any hardcopy reports on Click the button below to request a report when hardcopies become available.

Archived Annual Reports

About Esperion Therapeutics Inc

11-50 Employees
Based in Ann Arbor, Michigan

Esperion Therapeutics, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of oral and low-density lipoprotein cholesterol lowering therapies for the treatment of patients with hypercholesterolemia and other cardiometabolic risk markers. Its products include ETC-1002, an oral molecule therapy that is in Phase 2b clinical trials to treat patients with hypercholesterolemia, as well as to lower levels of LDL-cholesterol, and avoid various side effects associated with LDL-cholesterol lowering therapies.

NASDAQ (See More NASDAQ Companies)
Biotechnology (See More Biotechnology Companies)
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol